Digital.CSIC > Biología y Biomedicina > Instituto de Biología Molecular y Celular del Cáncer de Salamanca (IBMCC) > (IBMCC) Artículos >




Closed Access item High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics

Authors:Santamaría, Carlos
Chillón, Maria del Carmen
García-Sanz, Ramón
Caballero, Dolores
Sarasquete, María Eugenia
Díaz-Mediavilla, J.
San Miguel, Jesús F.
González, Marcos
Issue Date:2009
Citation:Leukemia Research 33(12): 1706-1709 (2009)
Abstract:The PI3/AKT pathway is up-regulated in acute myeloid leukemia (AML), but its prognostic relevance in cytogenetically normal AML (CN-AML) is unclear. We evaluated RNA levels of AKT and two downstream substrates (FOXO3a-p27) in 110 de novo CN-AML, included in the Spanish PETHEMA therapeutic protocols. Patients with high FOXO3a gene expression displayed shorter OS (p = 0.015) and RFS (p = 0.048) than low FOXO3a expressers. Features selected in the multivariate analysis as having an independent prognostic value for a shorter survival were WBC > 50 × 109/L, age >65 years and high FOXO3a expression. We concluded that FOXO3a assessment could contribute to improve the molecular-based risk stratification in CN-AML. © 2009 Elsevier Ltd. All rights reserved.
Identifiers:doi: 10.1016/j.leukres.2009.04.024
issn: 0145-2126
Appears in Collections:(IBMCC) Artículos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.